2-(4-(4-Fluorophenoxy)phenylsulfonamido)-N-hydroxy-2-methylpropanamide

Catalog No. :
ACXZGU815
CAS No. :
210755-45-6
Molecular Formula :
C16H17FN2O5S
Molecular Weight :
368.39

IUPAC Name:2-((4-(4-fluorophenoxy)phenyl)sulfonamido)-N-hydroxy-2-methylpropanamide

2-(4-(4-Fluorophenoxy)phenylsulfonamido)-N-hydroxy-2-methylpropanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg97%$375.00Login to see priceInquiryInquiry
50mg97%$885.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-(4-Fluorophenoxy)phenylsulfonamido)-N-hydroxy-2-methylpropanamide
IUPAC Name2-((4-(4-fluorophenoxy)phenyl)sulfonamido)-N-hydroxy-2-methylpropanamide
Molecular FormulaC16H17FN2O5S
Molecular Weight368.39
SMILESCC(C)(NS(=O)(C1=CC=C(OC2=CC=C(F)C=C2)C=C1)=O)C(NO)=O
InChI KeyQCOQJYRPDUMCNP-UHFFFAOYSA-N
SynonymPF-1626077;CP 471,474;2-[[[4-(4-Fluorophenoxy)phenyl]sulfonyl]amino]-N-hydroxy-2-methylpropanamide;2-(4-(4-Fluorophenoxy)phenylsulfonamido)-N-hydroxy-2-methylpropanamide;Propanamide, 2-[[[4-(4-fluorophenoxy)phenyl]sulfonyl]amino]-N-hydroxy-2-methyl-
CAS No.210755-45-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACXZGU815 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXZGU815 route product structure diagram
    ACXZGU815210755-45-6
Inquiry

2. ACXZGU815 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXZGU815 route product structure diagram
    ACXZGU815210755-45-6
Inquiry

Comments (0)